Huma named for its successful and innovative approach to clinical trials in new UK government review
Huma Therapeutics ("Huma"), a leading global digital health company, is named today as an exemplar of innovation in medical research in an independent review led by former Health Minister, Lord James …
OTE0001
Huma and UCB partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis
Huma Therapeutics ("Huma"), a leading global digital health company, and UCB, a global biopharmaceutical company, are partnering to offer a digital technology solution to help patients with the rare …
OTE0001
Huma receives world's first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform
Huma Therapeutics ("Huma"), a leading global digital health company, today announced that it has become the only company in the world to receive EU MDR 2017/745 Class IIb certification for a disease …
OTE0001
Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics ("Huma"), a leading global digital health company, today announced a partnership with Camden Health Partners and UCLPartners to deliver a digital-first programme aimed at identifying more …
OTE0003
Bayer Partners with Huma on Bayer® Aspirin Heart Risk Assessment Online Educational Tool to Raise Awareness of Heart Health and its Risk Factors
Huma's predictive algorithm will power a new global online patient engagement tool* that provides an accessible solution for heart health education
OTE0001
Largest decentralised study of its kind shows high levels of engagement with Huma's study app
Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced results of a new study in collaboration with the Medical Research Council Epidemiology Unit at the University of …
OTE0001
Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis
Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced that it has acquired Alcedis GmbH ("Alcedis"), a market-leader for data driven clinical research and technology.
OTE0001
